Voxel shows progress at RSNA show

Article

Medical holography developer Voxel displayed the progress it is making toward financial health at this month's Radiological Society of North America meeting in Chicago. The Laguna Hills, CA, company is close to finalizing its sale to a Florida holography

Medical holography developer Voxel displayed the progress it is making toward financial health at this month's Radiological Society of North America meeting in Chicago. The Laguna Hills, CA, company is close to finalizing its sale to a Florida holography company. Voxel also rolled out a new business strategy that it believes is more in line with most hospitals' capital equipment purchasing.

Voxel has been operating under the protection of a California bankruptcy court since June, after it was unable to pay an arbitration award of $1.9 million to former manufacturing partner General Scanning of Watertown, MA. In September, Voxel announced that its bankruptcy trustee had agreed to sell the company to Holographic Dimensions, a Miami-based firm that is interested in entering the medical imaging market (SCAN 9/30/98). That deal should be complete by the end of this year, according to Raymond Schulz, Voxel's director of marketing and one of five Voxel employees who remain at the company.

In Voxel's booth at the RSNA meeting, the company discussed its new business strategy of selling its 3-D holographic Voxgram images to hospitals on a per-use basis, rather than requiring healthcare facilities to buy the equipment to both produce and read Voxgrams themselves. Hospitals can send CT or MRI data over the Internet to Voxel, which will produce the holograms using its in-house holographic camera and ship the Voxgrams back to the facility overnight for $150. Hospitals must still purchase a special holographic light box to read the images, at a cost of $1500.

Voxel executives believe the new strategy will lower the cost at which hospitals can begin using Voxel technology. Under the company's prior strategy, hospitals had to lease holographic equipment at a cost of $75,000 over four years. Voxel's technology is reimbursable under a CPT code that pays about $133 for 3-D reconstruction and/or holography of CT and MRI images, according to Schulz.

Recent Videos
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
Related Content
© 2025 MJH Life Sciences

All rights reserved.